Abstract:OBJECTIVE:To explore the effect of micro ribonucleic acid (miRNA)-146a on kidney injury in mice with systemic lupus erythematosus (SLE), and to investigate its possible mechanism.MATERIALS AND METHODS:A total of 45 female MRL/lpr mice were randomly divided into control group, miR-146a mimic group and miR-146a inhibitor group. Urine protein level was measured every 2 weeks. Meanwhile, the levels of serum anti-dsdeoxyribonucleic acid (anti-dsDNA), anti-ssDNA, antinuclear antibody (ANA) and anti-chromatin were measured using enzyme-linked immunosorbent assay (ELISA). At 2 weeks after drug treatment, the effects of miR-146a mimic and inhibitor on kidney tissues of MRL/lpr mice were detected and analyzed by gene chip and gene set enrichment analysis, respectively. The mice were executed at the age of 24 weeks, and the blood samples were collected. Subsequently, the level of blood urea nitrogen (BUN) was measured using the BUN analyzer. After that, kidney tissues were taken, and the effect of drug treatment on the morphology of kidney tissues was detected via hematoxylin-eosin (HE) staining. Moreover, the effects of drug treatment on the mRNA levels of inflammatory factors and the nuclear factor-κB (NF-κB) signaling pathway in kidney tissues were detected via quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting, respectively.RESULTS:MiR-146a mimic significantly reduced urine protein in a time-dependent manner, which also significantly reduced BUN level at 24 weeks. The results of HE staining showed that both glomerular injury and renal vascular injury in miR-146a mimic group were significantly alleviated. In miR-146a mimic group, serum autoantibodies of anti-dsDNA, anti-ssDNA, anti-chromatin and ANA decreased significantly. However, the survival time of mice was significantly prolonged. High-throughput gene expression chip technique elucidated that in miR-146a mimic group, the expression of positive regulatory gene of NF-κB showed a decreasing trend. However, the expression of negative regulatory gene of NF-κB showed an increasing trend. MiR-146a mimic remarkably down-regulated the expression levels of RELA, IRAK1, interleukin-1B (IL1B) and IL-10 in kidney tissues. Furthermore, the results of Western blotting showed that miR-146a mimic inhibited both the classical and non-classical NF-κB signaling pathways.CONCLUSIONS:MiR-146a reduces SLE-induced kidney injury in MRL/lpr mice through regulating classical and non-classical NF-κB signaling pathways.

[Effect of Artemisinin on the Expressions of GRalpha Mrna, GRbeta Mrna and P300/CBP Protein in Lupus Nephritis Mice].

Effect of Artemisinin Combined with Glucocorticoid on the Expressions of Glucocorticoid Receptor Α Mrna, Glucocorticoid Receptor Β Mrna and P300/CBP Protein in Lupus Nephritis Mice.

Therapeutic Effect of Artemisinin on Lupus Nephritis Mice and Its Mechanisms.

Pathological Change and Mechanism of Artesunate Treatment for Lupus Nephritis in MRL/lpr Mice

Effect of artesunate on OAZ gene expressions in MRL/lpr lupus mice

Proteomics-Based Identification of Potential Therapeutic Targets of Artesunate in a Lupus Nephritis MRL/lpr Mouse Model

Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway

Immunosuppressive Effects of Hydroxychloroquine and Artemisinin Combination Therapy Via the Nuclear Factor-Κb Signaling Pathway in Lupus Nephritis Mice.

Artesunate relieves lupus nephritis by inhibiting the expression of ICAM-1

Therapeutic Effect Of Dihydroartemisinin On Lupus-Prone Mrl/Lpr Mice And Its Mechanism Of Action

Effects of artesunate on interstitial pneumonia and submaxillaritis in MRL/lpr mice

A Pilot Study of the Therapeutic Efficacy and Mechanism of Artesunate in the MRL/lpr Murine Model of Systemic Lupus Erythematosus

Effect of Hydroartemisinin on Lupus BXSB Mice

The Effect of Hydroxychloroquine Treatment on MRL/lpr Lupus Mice

Oral Administration of Artemisinin Analog Sm934 Ameliorates Lupus Syndromes in Mrl/Lpr Mice by Inhibiting Th1 and Th17 Cell Responses

MiR-146a Relieves Kidney Injury in Mice with Systemic Lupus Erythematosus Through Regulating NF-κB Pathway.

Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation

Effect of Arachidonic Acid Products on Lupus Nephritis of BXSB Mice

[Effects of Artemether and Dihydroarteannuin on Mouse Model of Scleroderma].

Artemisinin attenuates tubulointerstitial inflammation and fibrosis via the NF-κB/NLRP3 pathway in rats with 5/6 subtotal nephrectomy.

Dihydroartemisinin attenuated the symptoms of mice model of systemic lupus erythematosus by restoring the Treg/Th17 balance